Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Steven Pugh

Neurology Spokane, WA Medical Doctor

NPI 1952394272 CMS profile 361637

212 E Central Ave, Suite 440, Spokane, WA 99208

Open in the dashboard

General payments

$161,960

463 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$465,738 paid to institutions, not to them · program years 2019–2022

Through program year 2023, Steven Pugh of Spokane, WA is reported in the CMS Open Payments database as having received $161,960 across 463 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $465,738 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $213 4
2022 General $27,158 159
2021 General $13,232 36
2020 General $37,773 95
2019 General $83,584 169

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Pugh
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Steven Pugh were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Steven Pugh Neurology median Middle half National median
2019 $83,584 $474 $118–$2,177 $163
2020 $37,773 $367 $82–$2,309 $114
2021 $13,232 $438 $104–$2,547 $132
2022 $27,158 $442 $103–$2,388 $149
2023 $213 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Biogen, Inc. $39,864 77 payments
  2. EMD Serono, Inc. $35,021 69 payments
  3. Genzyme Corporation $25,800 62 payments
  4. E.R. Squibb & Sons, L.L.C. $23,700 22 payments
  5. Genentech USA, Inc. $16,839 29 payments
  6. Teva Pharmaceuticals USA, Inc. $9,178 12 payments
  7. Celgene Corporation $7,690 22 payments
  8. Novartis Pharmaceuticals Corporation $1,029 27 payments
  9. AbbVie, Inc. $364 17 payments
  10. Amgen Inc. $227 13 payments
  11. Other $2,249 113 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $109,061 57 payments
  2. Consulting Fee $26,380 9 payments
  3. Travel and Lodging $16,684 50 payments
  4. Food and Beverage $9,836 347 payments
Products named General payments · program years 2019–2023
  1. Mavenclad Neurology $25,413 26 payments
  2. ZEPOSIA $20,829 34 payments
  3. AUBAGIO Multiple Sclerosis $19,569 29 payments
  4. OCREVUS $16,866 29 payments
  5. TECFIDERA $14,898 23 payments
  6. TYSABRI $14,865 32 payments
  7. Mavenclad Neurology $8,390 27 payments
  8. COPAXONE $7,070 3 payments
  9. AUBAGIO Neurology $6,048 23 payments
  10. PLEGRIDY $5,160 10 payments
  11. Other $10,082 235 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

463 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record